Arkolith/Insider Trading/ELTX

ELTX Insider Trading

Elicio Therapeutics, Inc. · full profile →Last filing Aug 31, 2026

Elicio Therapeutics, Inc. also files under ANGN, ANG; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Aug 31, 2026Wilson Karen JDirectorGrant(A)22K—$0
Aug 31, 2026Venkatesan JayDirectorGrant(A)22K—$0
Aug 31, 2026Adams JulianDirectorGrant(A)22K—$0
Aug 31, 2026Ashe Carol GailDirectorGrant(A)22K—$0
Aug 31, 2026Chudnovsky YekaterinaDirector, 10% OwnerGrant(A)22K—$0
Aug 31, 2026Nissenson AllenDirectorGrant(A)22K—$0
Aug 31, 2026Ruffolo Robert RDirectorGrant(A)22K—$0
Jul 16, 2026DeMuth PeterChief Scientific OfficerGrant(A)53K—$0
Jul 16, 2026Shah PreetamSee RemarksGrant(A)61K—$0
Jul 16, 2026Haqq ChristopherSee RemarksGrant(A)65K—$0
Jul 16, 2026Connelly RobertCEO, President and Director, DirectorGrant(A)187K—$0
Feb 2, 2026DeMuth PeterChief Scientific OfficerGrant(A)42K—$0
Feb 2, 2026Shah PreetamSee RemarksGrant(A)24K—$0
Feb 2, 2026Shah PreetamSee RemarksGrant(A)48K—$0
Feb 2, 2026Connelly RobertCEO, President and Director, DirectorGrant(A)147K—$0
Feb 2, 2026Connelly RobertCEO, President and Director, DirectorGrant(A)74K—$0
Feb 2, 2026Haqq ChristopherSee RemarksGrant(A)51K—$0
Feb 2, 2026Haqq ChristopherSee RemarksGrant(A)25K—$0
Feb 2, 2026DeMuth PeterChief Scientific OfficerGrant(A)21K—$0
Dec 9, 2025DeMuth PeterChief Scientific OfficerOption exercise(M)362—$0
Dec 9, 2025DeMuth PeterChief Scientific OfficerOption exercise(M)362$4.41$2K
Jun 3, 2025Chudnovsky YekaterinaDirector, 10% OwnerGrant(A)103K—$0
May 19, 2025Ashe Carol GailDirectorGrant(A)8K—$0
May 19, 2025Chudnovsky YekaterinaDirector, 10% OwnerGrant(A)8K—$0
May 19, 2025Ruffolo Robert RDirectorGrant(A)8K—$0
May 19, 2025Wilson Karen JDirectorGrant(A)8K—$0
May 19, 2025Adams JulianDirectorGrant(A)8K—$0
May 19, 2025Venkatesan JayDirectorGrant(A)8K—$0
May 19, 2025Nissenson AllenDirectorGrant(A)8K—$0
Apr 15, 2025Shah PreetamSee RemarksGrant(A)192K—$0
Mar 5, 2025Chudnovsky YekaterinaDirector, 10% OwnerConversion(C)3.5M$5.81$20.3M
Mar 5, 2025Chudnovsky YekaterinaDirector, 10% OwnerConversion(C)3.4M$5.81$20.0M
Feb 3, 2025DeMuth PeterChief Scientific OfficerGrant(A)44K—$0
Feb 3, 2025Connelly RobertCEO, President and Director, DirectorGrant(A)122K—$0
Feb 3, 2025Haqq ChristopherSee RemarksGrant(A)44K—$0
Dec 16, 2024DeMuth PeterChief Scientific OfficerOption exercise(M)381—$0
Dec 16, 2024DeMuth PeterChief Scientific OfficerOption exercise(M)381$4.41$2K
Nov 26, 2024Venkatesan JayDirectorOption exercise(X)50K—$0
Nov 26, 2024Venkatesan JayDirectorOption exercise(X)50K$0.01$500
Nov 21, 2024Nissenson AllenDirectorGrant(A)4K—$0
Nov 21, 2024Wilson Karen JDirectorGrant(A)4K—$0
Nov 21, 2024Adams JulianDirectorGrant(A)4K—$0
Nov 21, 2024Ashe Carol GailDirectorGrant(A)4K—$0
Nov 21, 2024Venkatesan JayDirectorGrant(A)4K—$0
Nov 21, 2024Ruffolo Robert RDirectorGrant(A)4K—$0
Nov 21, 2024Chudnovsky YekaterinaDirector, 10% OwnerGrant(A)4K—$0
Sep 30, 2024Connelly RobertCEO, President and Director, DirectorGrant(A)92K—$0
Sep 30, 2024Haqq ChristopherSee RemarksGrant(A)28K—$0
Sep 30, 2024DeMuth PeterChief Scientific OfficerGrant(A)30K—$0
Aug 12, 2024Chudnovsky YekaterinaDirector, 10% OwnerBuy(P)3.4M$5.81$20.0M
Jun 28, 2024Venkatesan JayDirectorBuy(P)50K—$0
Jun 28, 2024Venkatesan JayDirectorBuy(P)50K$4.99$250K
Jun 28, 2024Chudnovsky YekaterinaDirector, 10% OwnerBuy(P)1.6M—$0
Jun 28, 2024Chudnovsky YekaterinaDirector, 10% OwnerBuy(P)1.6M$4.99$8.0M
Mar 19, 2024GKCC, LLC10% OwnerBuy(P)1.0M$5.81$6.0M
Feb 1, 2024Connelly RobertCEO, President and Director, DirectorGrant(A)225K—$0
Feb 1, 2024Piekos BrianChief Financial OfficerGrant(A)43K—$0
Feb 1, 2024Haqq ChristopherSee RemarksGrant(A)28K—$0
Feb 1, 2024DeMuth PeterChief Scientific OfficerGrant(A)342—$0
Feb 1, 2024DeMuth PeterChief Scientific OfficerGrant(A)30K—$0
Dec 28, 2023Nissenson AllenDirectorGrant(A)4K—$0
Dec 28, 2023Chudnovsky YekaterinaDirector, 10% OwnerGrant(A)4K—$0
Dec 28, 2023Wilson Karen JDirectorGrant(A)4K—$0
Dec 28, 2023Ruffolo Robert RDirectorGrant(A)4K—$0
Dec 28, 2023Ashe Carol GailDirectorGrant(A)4K—$0
Dec 28, 2023Venkatesan JayDirectorGrant(A)4K—$0
Dec 28, 2023Adams JulianDirectorGrant(A)4K—$0
Dec 22, 2023GKCC, LLC10% OwnerBuy(P)1.2M$5.81$7.0M
Jun 1, 2023Piekos BrianChief Financial OfficerGrant(A)75K—$0
Jul 1, 2022Goldberg ItzhakDirectorTax withholding(F)32K$1.12$36K
Jun 9, 2022Wilson Karen JDirectorGrant(A)15K—$0
Jun 9, 2022Ganzi Victor FDirectorGrant(A)15K—$0
Jun 9, 2022Nissenson AllenDirectorGrant(A)15K—$0
Jun 9, 2022Omenn Gilbert SDirectorGrant(A)15K—$0
May 25, 2022Venkatesan JaySee Remarks, DirectorBuy(P)11K$1.25$14K
May 24, 2022Venkatesan JaySee Remarks, DirectorBuy(P)32K$1.24$40K
May 20, 2022Nissenson AllenDirectorBuy(P)2K$1.18$2K
May 20, 2022Venkatesan JaySee Remarks, DirectorBuy(P)50K$1.23$62K
May 19, 2022Nissenson AllenDirectorBuy(P)7K$1.16$9K
Mar 3, 2022Venkatesan JaySee RemarksGrant(A)160K—$0
Mar 3, 2022Venkatesan JaySee RemarksGrant(A)600K—$0
Mar 2, 2022Neylan John F.See RemarksGrant(A)175K—$0
Mar 2, 2022Curhan Gregory SSee RemarksGrant(A)100K—$0
Mar 2, 2022Rhodes Jennifer JSee RemarksGrant(A)175K—$0
Mar 2, 2022Rhodes Jennifer JSee RemarksGrant(A)100K—$0
Mar 2, 2022Neylan John F.See RemarksGrant(A)100K—$0
Dec 28, 2021Venkatesan JaySee Remarks, DirectorBuy(P)210K$2.66$559K
Dec 27, 2021Venkatesan JaySee Remarks, DirectorBuy(P)67K$2.55$171K
Dec 20, 2021Venkatesan JaySee Remarks, DirectorBuy(P)4K$2.54$9K
Dec 20, 2021Neylan John F.See RemarksSell(S)358$2.62$938
Dec 17, 2021Venkatesan JaySee Remarks, DirectorBuy(P)14K$2.54$35K
Dec 16, 2021Venkatesan JaySee Remarks, DirectorBuy(P)28K$2.55$71K
Dec 15, 2021Curhan Gregory SSee RemarksBuy(P)4K$2.37$9K
Dec 15, 2021Venkatesan JaySee Remarks, DirectorBuy(P)78K$2.41$187K
Dec 14, 2021Rhodes Jennifer JSee RemarksSell(S)451$2.42$1K
Dec 6, 2021Goldberg ItzhakSee Remarks, DirectorSell(S)32K$3.35$108K
Dec 3, 2021Goldberg ItzhakSee Remarks, DirectorSell(S)40K$3.39$136K
Dec 2, 2021Goldberg ItzhakSee Remarks, DirectorSell(S)39K$3.51$136K
Dec 1, 2021Goldberg ItzhakSee Remarks, DirectorSell(S)39K$3.54$138K
Nov 18, 2021Neylan John F.See RemarksSell(S)374$4.13$2K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Elicio Therapeutics, Inc., SEC CIK 0001601485. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ELTX and shows every filing by that issuer (also filed as ANGN, ANG).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for ELTX